An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin.
A 14-week single-center clinical usage study was conducted to test the efficacy of a peptide treatment serum and supporting skincare regimen in 29 women with mild to moderately photodamaged facial skin. The peptide treatment serum contained gamma-aminobutyric acid (GABA) and various peptides with neurotransmitter inhibiting and cell signaling properties. It was hypothesized that the peptide treatment serum would ameliorate eye and facial expression lines including crow's feet and forehead lines. The efficacy of the supporting skincare regimen was also evaluated. An expert investigator examined the subjects at rest and at maximum smile. Additionally, the subjects completed self-assessment questionnaires. At week 14, the expert investigator found a statistically significant improvement in facial lines, facial wrinkles, eye lines, and eye wrinkles at rest when compared to baseline results. The expert investigator also found statistically significant improvement at week 14 in facial lines, eye lines, and eye wrinkles when compared to baseline results at maximum smile. In addition, there was continued highly statistically significant improvement in smoothness, softness, firmness, radiance, luminosity, and overall appearance at rest when compared to baseline results at the 14-week time point. The test regimen was well perceived by the subjects for efficacy and product attributes. The products were well tolerated with no adverse events. <br /><br /> <em>J Drugs Dermatol.</em> 2016;15(9):1100-1106.
Zoe Diana
ZD
Draelos
Tatiana
T
Kononov
Theresa
T
Fox
D000287:Administration, Topical; D000328:Adult; D005145:Face / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D010446:Peptide Fragments / Q000008:administration & dosage*; D012647:Self-Assessment; D015595:Skin Aging / Q000187:drug effects* / Q000473:pathology; D063465:Skin Cream / Q000008:administration & dosage*; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage*
D010446:Peptide Fragments; D005680:gamma-Aminobutyric Acid